Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Effect of Lomitapide Treatment on Major Adverse Cardiovascular Events (MACE) in Patients With Homozygous Familial Hypercholesterolemia: A Multicenter, Retrospective and Prospective Observational Study

NCT06832371 is registered in ClinicalTrials.gov with Fondazione SISA (Societa Italiana per lo Studio della Arteriosclerosi) as lead sponsor.

NCT NCT06832371
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06832371 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Effect of Lomitapide Treatment on Major Adverse Cardiovascular Events (MACE) in Patients With Homozygous Familial Hypercholesterolemia: A Multicenter, Retrospective and Prospective Observational Study
Lead sponsor
Fondazione SISA (Societa Italiana per lo Studio della Arteriosclerosi)
Phase
Observational
Overall status
Active, not recruiting
Start date
September 9, 2024
Completion date
December 31, 2026
Enrollment
73 (actual)
Sites
30

Conditions

As the registry lists them; a condition with its own page is linked.

dyslipidemia, homozygous familial hypercholesterolemia (hofh), major adverse cardiovascular events (mace)